{
    "Trade/Device Name(s)": [
        "MINICAP Hb A1c",
        "MINICAP FLEX-PIERCING",
        "Hb A1c CAPILLARY Calibrators",
        "Hb A1c CAPILLARY Controls"
    ],
    "Submitter Information": "SEBIA",
    "510(k) Number": "K133344",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122101"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JIS",
        "JJX"
    ],
    "Summary Letter Date": "March 28, 2014",
    "Summary Letter Received Date": "February 20, 2014",
    "Submission Date": "February 18, 2014",
    "Regulation Number(s)": [
        "21 CFR 864.7470",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube",
        "K3EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "MINICAP FLEX-PIERCING"
    ],
    "Method(s)/Technology(ies)": [
        "Capillary electrophoresis"
    ],
    "Methodologies": [
        "Separation and quantification of HbA1c by capillary electrophoresis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Calibrator",
        "Control",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for MINICAP Hb A1c kit, controls, and calibrators using MINICAP FLEX-PIERCING instrument for HbA1c quantification in whole blood by capillary electrophoresis.",
    "Indications for Use Summary": "Intended for separation and quantification of HbA1c fraction of hemoglobin in human whole blood, effective for monitoring long-term glycemic control in diabetic individuals, for professional in vitro diagnostic use only.",
    "fda_folder": "Hematology"
}